CancerLinQ, FDA expand real-word data collaboration

The CancerLinQ LLC data analysis subsidiary of the American Society of Clinical Oncology (ASCO) has expanded its real-world data collaboration with FDA to include data services companies Concerto HealthAI (Los Altos, Calif.) and Tempus Labs Inc. (Chicago, Ill.).

In June 2017, CancerLinQ and FDA teamed up to examine real-world use of cancer treatments including checkpoint inhibitors to inform patient care, cancer surveillance, and future regulatory decision-making. Cancer LinQ shared its research and analytics platform with FDA, which was created by ASCO and has more than 10,000 de-identified patient records from cancer patients treated with checkpoint inhibitors...